301 related articles for article (PubMed ID: 7904088)
1. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
[TBL] [Abstract][Full Text] [Related]
2. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the histamine H(2) receptor in monkey brain and its mRNA localization in monkey and human brain.
Honrubia MA; Vilaró MT; Palacios JM; Mengod G
Synapse; 2000 Dec; 38(3):343-54. PubMed ID: 11020238
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.
Palacios JM; Chinaglia G; Rigo M; Ulrich J; Probst A
Synapse; 1991 Feb; 7(2):114-22. PubMed ID: 1672780
[TBL] [Abstract][Full Text] [Related]
6. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
7. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
Watson DL; Carpenter CL; Marks SS; Greenberg DA
Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667
[TBL] [Abstract][Full Text] [Related]
8. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease.
Martinez-Mir MI; Probst A; Palacios JM
Neuroscience; 1991; 42(3):697-706. PubMed ID: 1835521
[TBL] [Abstract][Full Text] [Related]
10. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.
Richfield EK; Herkenham M
Ann Neurol; 1994 Oct; 36(4):577-84. PubMed ID: 7944290
[TBL] [Abstract][Full Text] [Related]
11. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
12. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
[TBL] [Abstract][Full Text] [Related]
13. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
14. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
[TBL] [Abstract][Full Text] [Related]
15. Huntington's disease: survival of large striatal neurons in the rigid variant.
Bugiani O; Tabaton M; Cammarata S
Ann Neurol; 1984 Feb; 15(2):154-6. PubMed ID: 6230987
[TBL] [Abstract][Full Text] [Related]
16. Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.
Kish SJ; Shannak K; Hornykiewicz O
Ann Neurol; 1987 Sep; 22(3):386-9. PubMed ID: 2445259
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia.
Allen AM; MacGregor DP; Chai SY; Donnan GA; Kaczmarczyk S; Richardson K; Kalnins R; Ireton J; Mendelsohn FA
Ann Neurol; 1992 Sep; 32(3):339-44. PubMed ID: 1416803
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
Bédard C; Wallman MJ; Pourcher E; Gould PV; Parent A; Parent M
Parkinsonism Relat Disord; 2011 Sep; 17(8):593-8. PubMed ID: 21664855
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
